Intensity Therapeutics In...

NASDAQ: INTS · Real-Time Price · USD
0.33
-0.25 (-43.01%)
At close: Jun 12, 2025, 3:59 PM

Intensity Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Mar 31, 2021
Cash & Equivalents
929K 2.59M 2.78M 3.24M 7.46M 8.56M 6.69M 135.76K 616.51K 1.31M 696.57K 1.72M 3.04M 4.54M 7.41M 8.11M
Short-Term Investments
n/a n/a n/a 3.08M 3.04M 6.22M 8.96M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 50K
Other Long-Term Assets
1.3M 1.3M 1.3M 1.1M 1.1M 1.68M 28.44K 167.74K 167.74K 167.74K 167.74K 167.74K 181.54K 167.74K 49.59K 182.1K
Receivables
n/a n/a n/a n/a n/a n/a 14.37K 17.84M 72.41K 62.3K 56.43K 67.9K 63.53K 51.26K 47.22K 60.13K
Inventory
n/a n/a n/a n/a n/a n/a 956.87K n/a 38.64K 29.36K n/a 60.37K 150.61K 70.44K 171.82K n/a
Other Current Assets
722K n/a n/a 1.12M n/a 6K n/a 5.58K 17.58K 46.8K 73.63K 26.61K 13.63K 69.28K 70.66K 7.67K
Total Current Assets
1.65M 3.36M 3.79M 7.44M 11.17M 15.46M 16.63M 18.06M 745.14K 1.45M 852.82K 1.88M 3.27M 4.73M 7.7M 8.26M
Property-Plant & Equipment
116K 122K 128K 135K 141K 147K 152.6K n/a 38.62K 139.09K 184.52K 229.5K 274.03K 318.13K 361.79K 447.84K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.41M 1.42M 1.43M 1.23M 1.24M 1.83M 181.04K 167.74K 206.35K 306.83K 352.26K 397.24K 455.57K 485.86K 411.37K 679.93K
Total Assets
3.06M 4.78M 5.21M 8.67M 12.41M 17.3M 16.82M 18.23M 951.49K 1.76M 1.21M 2.27M 3.72M 5.22M 8.11M 8.94M
Account Payables
1.59M 1.22M 540K 1.92M 1.22M 3.05M 358.4K 1.58M 899.44K 603K 796.3K 463.34K 539.89K 172.51K 295.1K 205.16K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
29K 28K 28K 27K 26K 20K 10.56K n/a 4.48M 4.35M 2.25M 2.05M 2.03M 2.02M 2M 173.96K
Other Current Liabilities
1.01M 452K 616K 812K n/a 479K -10.56K n/a n/a -655 2.06M n/a n/a n/a n/a 849.3K
Total Current Liabilities
2.63M 1.75M 2.32M 3.2M 2.52M 3.96M 723.97K 3.06M 6.88M 6.82M 5.38M 4.67M 4.37M 3.72M 4.42M 1.51M
Long-Term Debt
102K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a 36K 36K 36K 36K 10.04M 10.04M 36K 10.04M 10.04M 10.04M 10.04M 36K
Total Long-Term Liabilities
102K 110K 117K 124K 167K 174K 180.89K 36K 10.04M 10.04M 36K 10.08M 10.13M 10.18M 10.23M 317.6K
Total Liabilities
2.73M 1.86M 2.43M 3.33M 2.69M 4.13M 904.86K 3.09M 16.91M 16.85M 5.42M 14.75M 14.5M 13.9M 14.65M 1.83M
Total Debt
131K 138K 145K 151K 157K 158K 155.45K n/a 4.52M 4.49M 2.25M 2.28M 2.31M 2.34M 2.37M 455.56K
Common Stock
2K 2K 1K 1K 1K 1K 1.37K 1.31K 341.00 341.00 682.00 682.00 682.00 682.00 682.00 682.00
Retained Earnings
-70.13M -66.78M -63.6M -60.09M -55.12M -50.52M -47.34M -45.01M -39.99M -38.65M -37.14M -35.37M -33.44M -31.07M -28.67M -24.65M
Comprehensive Income
n/a n/a n/a n/a n/a -17.3M -16.82M -78.31B n/a n/a -682 n/a n/a -31.07M n/a -682
Shareholders Equity
334K 2.92M 2.78M 5.34M 9.72M 13.16M 15.91M 15.13M -15.96M -15.1M -4.21M -12.48M -10.78M -8.68M -6.54M 7.12M
Total Investments
n/a n/a n/a 3.08M 3.04M 6.22M 8.96M n/a n/a n/a n/a n/a n/a n/a n/a 50K